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Background: Single-cell network profiling (SCNP) is a multiparametric flow cytometry-based approach that simultaneously
measures evoked signaling in multiple cell subsets. Previously, using the SCNP approach, age-associated immune
signaling responses were identified in a cohort of 60 healthy donors.
Methods: In the current study, a high-dimensional analysis of intracellular signaling was performed by measuring
24 signaling nodes in 7 distinct immune cell subsets within PBMCs in an independent cohort of 174 healthy
donors [144 elderly (>65 yrs); 30 young (25–40 yrs)].
Results: Associations between age and 9 immune signaling responses identified in the previously published 60
donor cohort were confirmed in the current study. Furthermore, within the current study cohort, 48 additional
immune signaling responses differed significantly between young and elderly donors. These associations spanned
all profiled modulators and immune cell subsets.
Conclusions: These results demonstrate that SCNP, a systems-based approach, can capture the complexity of the
cellular mechanisms underlying immunological aging. Further, the confirmation of age associations in an independent
donor cohort supports the use of SCNP as a tool for identifying reproducible predictive biomarkers in areas such
as vaccine response and response to cancer immunotherapies.
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Due to an age-related decline in the function of the im-
mune system, the elderly are more susceptible to infectious
diseases and less likely to mount a sufficient response to
vaccination [1,2]. However, the mechanisms underlying
immunosenescence are incompletely understood. While
mouse models have helped to reveal age-associated defects
in T cells [3], due to species-specific differences in im-
munological aging, scientific findings in mice do not
always translate directly to humans [4]. Recent studies
of age-related immunological defects in human samples
have been highly focused on characterizing age-associated
changes in T cells [5]. Thus, such studies are often* Correspondence: rachael.hawtin@nodality.com
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precludes the identification of age-associated changes
in the multitude of immune cell types intentionally removed/
depleted from the purified sample. Further, traditional
immunological studies often utilize population-level ap-
proaches such as Western blots which fail to capture
heterogeneity within the cell population/subpopulation
under scrutiny. A systems biology approach capable of
capturing the functional behavior of the multiple cell
types that interact within the human immune system
is necessary to gain a comprehensive understanding
of the complex mechanisms responsible for immuno-
logical aging.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Summary of donor numbers, age, and gender
Published study
(Training set)
Current study
(Test set)
Number of donors 60 174
Median age (Range) 48 (19–73) yrs 68 (25–83) yrs
Gender 48 Male 78 Male
12 Female 96 Female
Donor characteristics are shown for the previously published study (training
set) and in the current study (test set) cohort. Age distributions for both
cohorts are shown in Figure 1.
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Figure 1 Distributions of donor ages. Histograms of donors’ ages
in the previously published (training) donor cohort (A) and in the
current study (test) donor cohort (B).
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lysis that can simultaneously measure both phenotypic
surface markers and intracellular signaling proteins in
response to extracellular modulation in multiple cell sub-
types within heterogeneous populations, including PBMCs
[6]. Thus, SCNP allows for a high-dimensional analysis
of age-related changes in immune cell function and can
provide a more holistic, systems-level view of immune cell
signaling networks in the aging immune system. Recent
work has demonstrated the utility of SCNP in identifying
associations between immune cell signaling responses and
age within distinct immune cell subsets in samples from
healthy donors [7,8].
In the current study, SCNP was applied to perform a
multi-dimensional analysis of intracellular immune sig-
naling in an independent cohort of healthy donors con-
sisting of 144 elderly donors and 30 young donors.
Overall, 168 immune signaling responses (i.e. 24 signal-
ing nodes, or combinations of modulator and intracellu-
lar readout, within 7 distinct immune cell subsets) were
measured in PBMCs from the 174 healthy donors. Based
on analyses of the previously published 60 donor cohort,
11 age-associated changes in cell signaling responses in
CD45RA+ T cell subsets were pre-specified for testing in
this current, independent study cohort and 9 of these
age associations were verified. The confirmation of age
associations in an independent donor cohort supports
the use of the SCNP technology as a tool for identifying
reproducible predictive biomarkers in areas such as vac-
cine response and response to cancer immunotherapies.
In a broader exploratory analysis of age-related immune
signaling changes performed in the current donor cohort,
57 immune signaling responses (61% of the 93 responsive
signaling nodes) were significantly associated with age. The
age-associated signaling responses spanned all modulators
(IFN-α, IFN-γ, IL-2, IL-4, IL-6, IL-10, IL-27, anti-IgD, LPS,
R848, PMA, and CD40L) and all subsets (monocytes,
B cells, CD3-CD20- lymphocytes (NK cell-enriched
subpopulation), CD45RA+Th cells, CD45RA- Th cells,
CD45RA+ cytotoxic T cells, and CD45RA- cytotoxic T
cells) demonstrating the importance of a holistic approach
to describing immunosenescence.
Methods
Participants and PBMC samples
The current study was registered with ClinicalTrials.gov
(NCT01119703) and approved by an independent Canadian
institutional review board. Participants were 174 healthy
residents of Quebec who gave written informed consent
prior to collection of blood samples. They were aged ei-
ther ≥ 65 or 25–40 yrs (Table 1, Figure 1B), of European
ancestry, and 55% female.
Blood was collected into sodium heparin Vacutainer®
tubes (Becton-Dickinson) from which PBMCs were isolatedand cooled within 8 h of collection. Briefly, heparinized
blood was diluted 1:1 with RPMI-1640 medium and over-
laid on ficoll/hypaque for centrifugation – all at room
temperature. Resultant PBMC were washed twice with
RPMI, resuspended in ice-cold 10% DMSO/90% heat-
inactivated FBS at a concentration of 10 million cells per ml,
and frozen slowly using a -1°C/min device to -80°C. Cells
were placed into liquid nitrogen temperatures within 72 h
of freezing and transported in a liquid nitrogen dry ship-
per. All samples had viabilities >70% based on cleaved
poly (ADP-ribose) polymerase negativity.
The PBMC samples from the 60 healthy donors used
for training purposes have been described previously [7].
Briefly, cryopreserved PBMC samples were collected
from healthy donors within the Department of Transfusion
Table 2 Signaling nodes measured
Signaling node Measured in prior study
IFN-α→ p-Stat1 Yes
IFN-α→ p-Stat3 Yes
IFN-α→ p-Stat5 Yes
IFN-α→ p-Stat6 Yes
IL-2→ p-Stat5 Yes
IL-2→ p-Stat6 Yes
IL-4→ p-Stat5 Yes
IL-4→ p-Stat6 Yes
IL-6→ p-Stat1 Yes
IL-6→ p-Stat3 Yes
IL-27→ p-Stat1 Yes
IL-27→ p-Stat3 Yes
IL-27→ p-Stat5 Yes
IL-27→ p-Stat6 Yes
R848→ p-Erk Yes
R848→ p-NF-κB Yes
PMA→ p-S6 Yes
PMA→ p-Erk Yes
Anti-IgD→ p-S6 No
Anti-IgD→ p-Erk No
Anti-IgM→ p-ZAP70/p-Syk No
Anti-IgM→ p-Erk No
Anti-CD3→ p-ZAP70/p-Syk No
Anti-CD3→ p-Erk No
The following 24 signaling nodes (modulator and intracellular readout
combinations) were measured in the current study. The majority of these
signaling nodes (i.e. the 18 signaling nodes indicated above) were also
measured in the previously published study cohort [7]. All signaling nodes
were measured in 12 cell populations defined by their surface phenotypes
including 7 distinct immune cell subpopulations (monocytes, B cells,
CD3-CD20- lymphocytes (NK cell-enriched subpopulation), CD45RA+ Th cells,
CD45RA- Th cells, CD45RA+ cytotoxic T cells, and CD45RA- cytotoxic T cells).
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with institutional review board approval. All healthy
donors donated blood samples for research purposes with
informed consent.
SCNP assay and reagents
The SCNP assay was performed as described previously
[7]. Modulators and concentrations were as follows:
1000 IU/ml IFN-α (PBL); 50 ng/ml IL-4, 5 μg/ml anti-
IgD (BD Biosciences); 50 ng/ml IL-2, 50 ng/ml IL-6,
50 ng/ml IL-27, 5 μg/ml R848 (Invivogen); 40 nM PMA
(Sigma Aldrich), 3 μg/ml anti-CD3 (eBioscience), 10 μg/
ml anti-mouse (Santa Cruz Biotechnology), 10 μg/ml
anti-IgM (Southern Biotech). For TCR stimulation, cells
were exposed to anti-CD3 for 12 min, with anti-mouse
added for the last 2 min; the anti-IgM modulation time
was 10 min; all other modulation times were 15 min.
Staining was performed using Ab cocktails with each
cocktail consisting of 5 Abs to detect phenotypic markers
and 2 Abs to detect intracellular protein readouts. Abs
used include anti-CD3, −CD4, −CD45RA, −CD20, −p-
NF-κB, −c-poly(ADP-ribose) polymerase, −p-Stat1, −p-
Stat3, −p-Stat5, −p-Stat6, −p-Erk, −p-ZAP70/Syk (BD
Biosciences); −p-Akt, −p-S6 (CST); and -CD14 (Beckman
Coulter). Flow cytometry data was acquired on FACS
Canto II Flow Cytometers (BD Biosciences). All flow
cytometry data were analyzed with WinList (Verity House
Software). PBMC subpopulations were delineated according
to the immunophenotypic gating scheme described previ-
ously [7].
SCNP terminology and metrics
The term “signaling node” refers to a specific protein
readout in the presence of a specific modulator. For ex-
ample, the response to IFN-α stimulation can be mea-
sured using p-Stat5 as a readout. This signaling node is
designated “IFN-α→ p-Stat5”. Each signaling node is
measured in each of the 7 distinct cell subpopulations
simultaneously. The cell subpopulation is noted follow-
ing the node e.g. “IFN-α→ p-Stat5 | CD45RA- Th cells”.
The raw instrument median fluorescence intensities
(MFIs) were converted to calibrated intensity metrics,
Equivalent Number of Reference Fluorophores (ERFs),
by using rainbow calibration particles on each 96-well
plate [9,10]. The “Fold” metric is applied to measure the
level of a signaling molecule after modulation compared
to its level in the unmodulated state.
The “Fold” metric was calculated as follows:
Fold: log2 [ERF(Modulated)/ERF(Unmodulated)]
Overall, 24 signaling nodes (Table 2), or modulated
protein readouts, were measured in 12 cell populations
defined by their surface phenotypes including 7 distinctimmune cell subpopulations (monocytes, B cells, CD3-
CD20- lymphocytes (NK cell-enriched subpopulation),
CD45RA+ Th cells, CD45RA- Th cells, CD45RA+ cyto-
toxic T cells, and CD45RA- cytotoxic T cells) within
unsorted PBMC samples from 174 healthy donors
(Table 1). In the current study, Th cells and cytotoxic
T cells are defined based on the differential expression
of CD4 (i.e. CD4+ cells are categorized as Th cells and
CD4- cells are categorized as cytotoxic T cells).
Statistical analysis
A train and test approach was utilized for verification of
associations between immune signaling response and
age in two independent healthy donor cohorts. Here, the
60 donor cohort (Table 1, Figure 1A) from a previously
published study (i.e. the master set in the prior cohort
Longo et al. Journal of Translational Medicine 2014, 12:178 Page 4 of 9
http://www.translational-medicine.com/content/12/1/178[7]) was used as a training set, and associations between
immune signaling responses and age were identified by
regressing age against each signaling node in each
distinct cell subset using a linear model. The p value
corresponding to the hypothesis that the slope is zero
was used as the significance test (with a p < 0.05 cutoff ).
Immune signaling responses with significant associations
with age in the 60 donor training set were pre-specified
for confirmation in the independent set of 174 healthy
donors in the current study (test) cohort. To control the
type I error rate, pre-specified age associations were
ranked (based on the strength of the association with
age in the training cohort) and tested using a Gatekeeper
strategy [11]. In this strategy, each hypothesis to be veri-
fied in the test set must be prospectively specified and
ordered, and subsequently tested in that order (here speci-
fied in Table 3). A hypothesis is only considered verified if
it is significant in the test set and all other hypotheses
tested prior to it are significant. In the test set, age associa-
tions were considered significant if p < 0.05 for the two-
sided Wilcoxon rank-sum test statistic. The Wilcoxon
rank-sum test was used for analyzing age associations
in the current study (test) cohort because this cohort
contained distinct young and elderly donor subgroups
(Figure 1B). Because the previously published (training)
cohort did not contain distinct donor subgroups based on
age (as shown by the age distribution in Figure 1A), linear
regression was used for analyzing age associations in that
cohort as described above.
To discount variation in cell viability as a causative
factor for signaling differences between young and
elderly donor subgroups, differences between the pro-
portions of viable cells were analyzed. No significant
association between cell viability and age was observed
(p = 0.237, Wilcoxon rank-sum test statistic).Table 3 Pre-specified hypotheses for testing in the current st
Hypothesis order SCNP Node | Cell subset
1 IL-2→ p-Stat5 | CD45RA+ Th cells
2 IFN-α→ p-Stat5 | CD45RA+ cytotoxic T cel
3 IL-27→ p-Stat5 | CD45RA+ cytotoxic T cell
4 IFN-α→ p-Stat1 | CD45RA+ cytotoxic T cel
5 IL-6→ p-Stat1 | CD45RA+ cytotoxic T cells
6 IL-4→ p-Stat6 | CD45RA+ cytotoxic T cells
7 IL-6→ p-Stat3 | CD45RA+ cytotoxic T cells
8 IFN-α→ p-Stat5 | CD45RA+ Th cells
9 IL-27→ p-Stat1 | CD45RA+ cytotoxic T cell
10 IFN-α→ p-Stat3 | CD45RA+ cytotoxic T cel
11 PMA→ p-S6 | CD45RA+ cytotoxic T cells
*This age-association is significantly associated with age in the test cohort, but not
were sequentially ordered for testing using a Gatekeeper strategy. A p value < 0.05Results and Discussion
Verification of pre-specified associations between immune
signaling responses and age in independent healthy donor
cohorts
The master set of 60 donors from the published study
[7] was utilized as a training data set and, among the
panel of immune signaling responses profiled (Table 2)
in the training cohort, responses with significant associa-
tions with age (based on linear regression analysis, see
Methods) were identified. Eleven immune signaling re-
sponses (Table 3) that were significantly associated with
age in the 60 donor training set were pre-specified for
confirmation in the current study (test) cohort of 174
healthy donors (Table 1). Despite profiling a broad panel
of signaling pathways across multiple immune cell
subsets (Figure 2, Table 2), all of the immune signaling
responses with significant associations with age in the
60 donor training cohort (i.e. the 11 pre-specified
hypotheses), were within CD45RA+ T cell subsets. This
result is consistent with reports that age-related defects
in immune cell function are most pronounced within
the naïve T cell compartment [12].
Using a Gatekeeper strategy (see Methods), 9 of the 11
pre-specified age-associated signaling responses were
verified in the independent cohort of 174 donors (test
set) in the current study. Figure 3 shows the range of
signaling in the elderly vs. the young donors for the 9
verified age-associated responses. The verified age associa-
tions included 7 immune signaling responses in the
CD45RA+ cytotoxic T cell subset. Specifically, in response
to the cytokines IFN-α, IL-4, IL-6, and IL-27, the elderly
donors had lower induced p-Stat levels in CD45RA+ cyto-
toxic T cells than the younger donors. An age-related
decline in the responsiveness of the JAK-STAT signaling
pathway within this cytotoxic T cell subset may contributeudy cohort
Wilcoxon p-value Hypothesis verified?
1.10 × 10−8 Yes
ls 5.65 × 10−10 Yes
s 9.38 × 10−11 Yes
ls 8.67 × 10−8 Yes
2.46 × 10−9 Yes
1.86 × 10−4 Yes
6.70 × 10−7 Yes
5.28 × 10−6 Yes
s 7.70 × 10−8 Yes
ls 0.180 No
4.82 × 10−6 No*
verified according to the requirements of the gatekeeper approach. Hypotheses
for the two-sided Wilcoxon rank-sum test statistic was considered significant.
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Figure 2 Diagram of the immune signaling pathways and cell subsets profiled in the current study cohort.
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to occur in cytotoxic T cells [13].
Within the CD45RA+ Th cell compartment, the veri-
fied associations included age-associated differences in
IFN-α-induced p-Stat5 and in IL-2-induced p-Stat5 re-
sponses. Notably, CD45RA+ Th cells displayed higher
IL-2-induced p-Stat5 in elderly donors than in young
donors. Because IL-2 production is reported to decrease
with age [14], the heightened responsiveness to IL-2 in
CD45RA+ Th cells observed in this study in the elderly
might be considered a compensatory mechanism. Clinic-
ally, the use of IL-2 as an immunotherapy has shown
promise in the treatment of cancers including renal cell
carcinoma and malignant melanoma [15]. IL-2 immuno-
therapy may help to restore the proliferative capacity of
naïve T cells in elderly cancer patients and may be a par-
ticularly effective approach for augmenting the effect of
checkpoint-related immunotherapies. However, the ef-
fectiveness of IL-2 immunotherapy may be limited if, as
suggested previously, the induction of p-Stat5 via IL-2 is
not directly coupled with proliferative responses due to
the presence of age-related defects in responsiveness
downstream of p-Stat5 induction [16].
Age-associated immune responses identified within the
current study cohort span all signaling pathways and
immune cell subsets profiled
Age-associated alterations in immune signaling re-
sponses were further explored within the current study
cohort by identifying all responses among the broadpanel of immunomodulators and immune cell subsets
profiled (Figure 2, Table 2) which differed significantly
between young and elderly donors. As shown in Figure 4,
across the 168 immune signaling responses measured
(i.e. 24 signaling nodes in 7 distinct cell subsets), 93 were
responsive (based on a Fold threshold of 0.25 represent-
ing an ~1.2-fold change in modulated levels relative to
basal, see Methods). The observed cell subset-specificity
in responsiveness was consistent with prior studies [7]
and expected based on reported cell-subset specific
expression of receptors for the ligands included in the
study. For example, for the TLR7/8 agonist, R848, the
observed responsiveness of the R848→ p-Erk and
R848→ p-NF-κB signaling nodes in monocytes and B
cells but not in T cell subsets (as indicated by the white
boxes in Figure 4) is consistent with the cell-subset
specific expression of the receptor (TLR7/8) on mono-
cytes and B cells.
Of the 93 responsive signaling nodes, 57 showed sig-
nificant age-associated differences with the majority
(51 nodes) displaying lower responsiveness in elderly
donors than in younger donors (purple boxes in
Figure 4). Targeted therapeutic re-activation of these
signaling responses may allow for restoration of im-
mune function in the elderly. Only 6 immune signaling
responses had a higher magnitude in elderly donors
than in the younger donors (green boxes in Figure 4).
These 6 responses include one of the verified hypotheses
(IL-2→ p-Stat5 | CD45RA+Th cells) discussed above,
IL-27→ p-Stat3 | CD45RA+ cytotoxic T cells, and 4
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http://www.translational-medicine.com/content/12/1/178signaling nodes (anti-IgD→ p-Erk, anti-IgD→ p-S6, anti-
IgM→ p-Syk, and R848→ p-NF-κB) in B cells. Because
memory B cells and naïve B cells differ in their responsive-
ness to many stimuli [17], the higher responsiveness
observed here for 4 signaling nodes in the overall parent
B cell population in elderly donors compared to youn-
ger donors may be reflective of the reported age-related
decline in memory B cells [18]. The hypothesis that the
higher signaling in elderly than in younger donors
following modulation with anti-IgD and anti-IgM is
related to a difference in proportion of B cell subsets is
further supported by previous work which has demon-
strated that there is a positive relationship between the
frequency of IgD + B cells and the magnitude of BCR
signaling responses detected in the parent B cell popula-
tion [19]. Future studies that include phenotypic
markers such as CD27 and IgD to delineate B cell sub-
populations are needed to investigate age-related differ-
ences in immune signaling responses within distinct B
cell subpopulations.
As noted above, the verified age-associated responses
(which differed significantly with age in both the current
study cohort and the previously published cohort) were
restricted to cytokine signaling responses in CD45RA+ T
cell subsets (indicated by asterisks in Figure 4). In
contrast, the 57 significant age-associated responses
identified within the current study cohort spanned all
modulators and all 7 distinct immune cell subsets
profiled in the 174 healthy donors. Notably, all of the
responsive signaling nodes in monocytes displayed
significant associations with age. Among the four T cell
subsets, 50% (both CD45RA- subsets) to 81% (CD45RA+
cytotoxic T cells) of the responsive signaling nodes dis-
played significant age associations. The NK-enriched
cell subset appears to be the least impacted by age, with
38% of the responsive signaling nodes within this subset
showing an association with age. Among the different
immunomodulators profiled, differences in the effect of
age on responsiveness were observed with some stimuli
(i.e. IL-6, IL-27, and IFN-α) displaying significant asso-
ciations with age for the majority of the responsive
intracellular readouts measured and other immuno-
modulators (i.e. α-CD3 and IL-4) having a relatively
small percentage (25%) of responsive intracellular read-
outs showing an association with age. Overall, these
results suggest that age-related alterations in immune cell
function are widespread, impacting multiple immune cell
types and immune signaling pathways, with some degree
of cell-subset specificity and stimulus-specificity in the
sensitivity to age-related changes.
In the exploratory analysis described here, because the
focus was on hypothesis generation, the less stringent
approach of utilizing p values that do not account for
multiple testing was employed. However, p values weresubsequently adjusted for multiple testing using the
Benjamini-Hochberg method to assess which age asso-
ciations remain significant with this more conservative
approach. Of the 57 age-associated signaling responses
with (unadjusted) p values < 0.05, 47 have adjusted p
values < 0.05. The 10 responses that lose significance
with the adjusted p values include the 9 responses in
Figure 4 with 0.01 < p < 0.05 and 1 response with p = 0.007
(IL-27→ p-Stat3 in CD45RA-cytotoxic T cells).
While a small number of the age-associated responses
identified in the current study were not profiled in the
previously published healthy donor cohort (Table 2), the
majority of responses were measured in both donor co-
horts. Age associations which reached statistical signifi-
cance in the current study cohort may have failed to
reach significance in the prior cohort for several possible
reasons: 1) there was lower power for detecting signifi-
cant differences in the prior study than in the current
study due to sample size differences (Table 1), 2) age-
associated differences may be more pronounced within
a cohort containing only young (<40 yrs) and elderly
(>65 yrs) donors than in a cohort in which the majority
of the donors are between 40–65 yrs (Figure 1), or 3)
some of the age-associations identified within the
current cohort could be “false positives”. While future
studies are needed to confirm many of the age associa-
tions identified by SCNP in the larger 174 healthy donor
cohort, other groups have previously reported a subset
of these age-associated alterations.
For example, an age-associated alteration in TCR sig-
naling (a pathway which was not profiled in the prior
study, see Table 2) is consistent with published reports
[20]. In fact, recent work has demonstrated that there is
an age-associated decline in TCR-induced Erk phosphor-
ylation in naïve Th cells, but no age associated difference
in other TCR-induced responses including ZAP70 in naïve
Th cells, and no age-associated difference for TCR-
induced responses in memory Th cells [21]. The results
of the current study are remarkably consistent with these
previously published reports [i.e. as shown in Figure 4,
1) there is a statistically significant association with age for
TCR-induced p-Erk in CD45RA+T cell subsets (predom-
inantly naïve T cells) but not in CD45RA- memory T cell
subsets and 2) TCR-induced p-ZAP70 is not significantly
associated with age in any of the T cell subsets]. By inte-
grating TCR signaling data with transcript expression
measurements, Li et al. have recently demonstrated that
the age-associated decline in TCR-induced Erk phosphor-
ylation in naïve Th cells is due to an age-related increase
in the phosphatase DUSP6 which is in turn a result of
an age-related decline in the expression of miR-181a ex-
pression [21]. In the present study, the T cell subsets
simultaneously profiled included not only the Th cell sub-
sets studied by Li et al. but also CD45RA+/−cytotoxic T
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associated decline in TCR-induced Erk phosphorylation
specifically within the CD45RA+ cytotoxic T cell compart-
ment (Figure 4), suggesting that a decline in miR-181a ex-
pression and thus DUSP6 activity may affect immune
signaling in an age-associated manner in the naïve cyto-
toxic T cell subset as well.
The age-associated decline in intracellular signaling re-
sponses in monocytes following modulation with the
TLR7/8 ligand R848 (Figure 4) is consistent with pub-
lished reports describing age-related alterations in TLR
responses. Specifically, van Duin et al. have reported re-
duced TLR-induced CD80 expression on monocytes
from older donors compared to younger donors [22]. In
our SCNP studies with a small number of PBMC samples
from healthy control donors, the magnitude of intracellu-
lar signaling responses following short-term (15 min)
TLR modulation has shown a positive correlation with
increased CD80 and CD86 expression following long-
term (~21 hr) modulation with the same TLR ligands
(data not shown).
Future work will focus on expanding the immune cell
subsets interrogated for age-associated signaling alter-
ations. The inclusion of phenotypic markers allowing for
the delineation of additional cell subsets, such as den-
dritic cells, will allow for a greater understanding of age-
related alterations in innate immunity [23]. Subsequent
studies including additional surface markers will also en-
able the analysis of increasingly homogeneous cell sub-
sets within the broader phenotypes described herein. For
example, the CD45RA+ cytotoxic T cell subset described
in the current study can be further subdivided into naïve
and effector cell subsets via the inclusion of markers
such as CD27, CD28, or CCR7. Because the composition
of the more heterogeneous CD45RA+ cytotoxic T cell
subset may change with age, it will be important to analyze
age-associated differences in immune signaling responses
in increasingly homogeneous cell subsets, building upon
the information obtained in the current study. The incorp-
oration of multiple time points following modulation will
further enable an analysis of age-associated differences in
signaling kinetics. Finally, analyses will integrate SCNP
intracellular signaling data with additional biomarkers gen-
erated from gene expression studies, cytokine production
analysis, and sequencing measurements.
Conclusions
In summary, SCNP provides quantitative, high dimen-
sional measurements of the human immune cell signaling
network pertinent to unraveling the complex mechanisms
underlying the age-related decline in the function of the
human immune system. The confirmation of age associa-
tions in two independent donor cohorts supports the util-
ity of SCNP as a tool for identifying associations betweenimmune signaling responses and clinical outcomes such
as response to classical prophylactic vaccines, therapeutic
cancer vaccines, or alternative immunotherapies.
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